Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 16/02/19991 min de leitura
Draft Guidance for Industry on Developing Medical Imaging Drugs and Biologics; Availability; Extension of Comment Period
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is extending until April 14, 1999, the comment period for the draft guidance for industry entitled ``Developing Medical Imaging Drugs and Biologics.'' FDA published a notice of availability of the draft guidance in the Federal Register of October 14, 1998 (63 FR 55067). FDA is taking this action in response to requests for an extension.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →